Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination
Abstract Over 26 million cases of coronavirus disease 2019 (COVID‐19) have been reported in the United States with over 440 000 deaths. Despite COVID‐19 vaccine approval, pregnant women were excluded from clinical trials. We report a case of immune thrombocytopenia in the first trimester, which occurred 13 days after initiating the COVID‐19 vaccination series. Thorough evaluation, including hematology consultation, established the diagnosis. High‐dose oral corticosteroids were started, and she was discharged home with significant improvement in platelet count on her fourth day of hospitalization with no subsequent complications. We advocate that the benefits of COVID‐19 vaccination outweigh the risk of infection in pregnancy and that pregnant women should be included in clinical trials. Closer post‐vaccination surveillance may be warranted in the pregnant population pending further data..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
|---|---|
| Enthalten in: |
Journal of Obstetrics and Gynaecology Research - 47(2021), 11, Seite 4077-4080 |
| Beteiligte Personen: |
Bennett, Carrie [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2021 Japan Society of Obstetrics and Gynecology |
|---|
| Umfang: |
4 |
|---|
| doi: |
10.1111/jog.14978 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY009193820 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY009193820 | ||
| 003 | DE-627 | ||
| 005 | 20230307184328.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230217s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/jog.14978 |2 doi | |
| 028 | 5 | 2 | |a JOG_JOG14978.xml |
| 035 | |a (DE-627)WLY009193820 | ||
| 035 | |a (WILEY)JOG14978 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.92 |2 bkl | ||
| 100 | 1 | |a Bennett, Carrie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination |
| 264 | 1 | |c 2021 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2021 Japan Society of Obstetrics and Gynecology | ||
| 520 | |a Abstract Over 26 million cases of coronavirus disease 2019 (COVID‐19) have been reported in the United States with over 440 000 deaths. Despite COVID‐19 vaccine approval, pregnant women were excluded from clinical trials. We report a case of immune thrombocytopenia in the first trimester, which occurred 13 days after initiating the COVID‐19 vaccination series. Thorough evaluation, including hematology consultation, established the diagnosis. High‐dose oral corticosteroids were started, and she was discharged home with significant improvement in platelet count on her fourth day of hospitalization with no subsequent complications. We advocate that the benefits of COVID‐19 vaccination outweigh the risk of infection in pregnancy and that pregnant women should be included in clinical trials. Closer post‐vaccination surveillance may be warranted in the pregnant population pending further data. | ||
| 700 | 1 | |a Chambers, Laura M. |4 aut | |
| 700 | 1 | |a Son, Ji |4 aut | |
| 700 | 1 | |a Goje, Oluwatosin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of Obstetrics and Gynaecology Research |g 47(2021), 11, Seite 4077-4080 |w (DE-627)WLY009188363 |x 14470756 |7 nnns |
| 773 | 1 | 8 | |g volume:47 |g year:2021 |g number:11 |g pages:4077-4080 |g extent:4 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 936 | b | k | |a 44.92 |q ASE |
| 951 | |a AR | ||
| 952 | |d 47 |j 2021 |e 11 |h 4077-4080 |g 4 | ||